Under the new regime, buyback proceeds are taxed as capital gains—12.5% for long-term holdings above ₹1.25 lakh, 20% for short-term—compared to dividend taxation at slab rates of 30-42% for high-income individuals. This creates 17.5-29.5% tax savings for retail shareholders, making buybacks significantly more efficient than dividends.
The impact was immediate and dramatic. Total buyback activity had declined 84.2% from ₹49,836 crores in FY 2023-24 to ₹7,897 crores in FY 2024-25 under the unfavorable deemed dividend regime. Post-April 2026, just these five companies announced ₹31,817 crores in buybacks—a 403% increase versus the entire previous year. The clustering of announcements from April 15 to May 19, 2026, demonstrates rapid strategic adaptation to this new tax-efficient framework.
The correlation between free cash flow generation relative to capex and buyback aggressiveness is striking. Bajaj Auto and Wipro demonstrate the strongest cases of excess cash driving buybacks.
Bajaj Auto's ₹5,633 crore buyback (1.68% of paid-up capital) is backed by exceptional cash metrics: free cash flow exceeding ₹8,000 crores, capex of only ₹500 crores split equally between ICE and EV investments, and surplus funds of over ₹18,000 crores. The FCF/Capex ratio of 16x indicates massive excess cash generation relative to near-term investment needs. Management's 100% payout of FY26 profits—split between ₹4,192 crores in dividends and ₹5,633 crores in buybacks—reflects a mature business stage with limited high-ROIC opportunities. Transcripts +1
Wipro's ₹15,000 crore buyback (5.72% of paid-up capital) represents the largest in company history and 114% of annual FCF. With an FCF/Capex ratio of 15.05x and operating cash flow at 112% of net income, Wipro generates exceptional cash with minimal capital-intensive growth opportunities. The company achieved an 88% payout ratio over the three-year block ending FY26, significantly exceeding its 70% minimum threshold. This massive capital return reflects constrained growth prospects in the IT sector, where macroeconomic uncertainty has led to muted discretionary investments and a 2.7% year-over-year revenue decline in FY25. Transcripts +2
CyberTech Systems presents an interesting case of scale-appropriate capital allocation. The company's ₹14.45 crore buyback represents 9.81% of paid-up capital—the highest percentage among analyzed companies. This decision reflects an exceptional FCF/Capex ratio of 25.15x, indicating limited internal reinvestment opportunities at current scale. Despite the small absolute size, the buyback represents 55.3% of annual FCF, signaling management's assessment that current scale constrains growth investments. The company maintains a debt-free balance sheet, providing flexibility for this capital return while preserving capacity for future opportunities. Others +2
Dhanuka Agritech and Zydus Lifesciences demonstrate more balanced approaches, reflecting moderate growth opportunities.
Dhanuka's ₹70 crore buyback (1.11% of paid-up capital) represents only 26.6% of FCF, with management retaining ~73% of cash flow for growth investments. The company is focusing on margin-accretive "9(3) product" portfolio expansion, new product launches, backward integration, and international expansion. The buyback at an 18.62% premium reflects confidence in long-term fundamentals while maintaining capacity for strategic initiatives. Transcripts +3
Zydus's ₹1,100 crore buyback (0.87% of paid-up capital after price increase) represents 35.3% of FCF, with the company maintaining substantial investment capacity. Management is planning ₹1,500 crores in capex for FY27 and investing approximately 8% of revenue expectations (~₹700 crore quarterly) in R&D. The buyback price increase from ₹1,150 to ₹1,260 per share—while maintaining the total amount—demonstrates growing confidence in intrinsic value despite significant growth investments in specialty pharmaceuticals and international expansion. Others +4
The buyback premiums of 11-24% during NIFTY50's 8.56% decline in 2026 represent deliberate contrarian signals of management confidence in intrinsic value.
Wipro's 24% premium—the highest among the five companies—is particularly significant given that the stock trades 26.2% below its 52-week high of ₹273.10. This premium reflects management's assessment that market prices are not adequately capturing the company's transformation progress, strong cash generation capacity, and strategic AI investments. Despite recent earnings pressure, Wipro's exceptional FCF generation and capital-efficient business model support confidence in long-term value. Transcripts +1
Zydus Lifesciences' increased its buyback price by 9.57% from ₹1,150 to ₹1,260 while maintaining the total ₹1,100 crore amount. This decision follows exceptional Q4 FY26 performance: revenues up 16% YoY, EBITDA margins of 33.7%, and net profit up 15% YoY. Management provided confident FY27 guidance expecting high teens revenue growth and margins exceeding 24%. The price increase demonstrates conviction that specialty business potential and international growth (40%+) are not reflected in current pricing. Others +6
Bajaj Auto's 11.02% premium is notable despite the stock trading at its 52-week high. This reflects management's view that record performance—32% revenue growth, 20.8% EBITDA margins, 34% PAT growth—warrants valuation beyond current market levels even at peak prices. Transcripts +1
Promoter participation patterns reveal different governance philosophies. Dhanuka Agritech's promoter group explicitly stated intention to participate despite the 30% promoter tax rate versus 12.5% for long-term retail shareholders. This participation reflects a calculated assessment that the 13.03% post-tax return (18.62% premium minus 30% tax) provides attractive risk-adjusted value versus uncertain future appreciation. However, this could increase promoter concentration from 69.71% to 70.82%, potentially reducing public float and minority influence. AnnualReports
Bajaj Auto's promoters may choose non-participation, which could increase their stake from 55.01% to 55.89% through the 1.68% buyback. This gradual concentration pattern—promoters have systematically increased holding from 53.70% to 55.01% over five years—suggests a strategic approach to enhancing control while returning capital to shareholders.
Wipro's promoters also indicated intention to participate in the ₹15,000 crore buyback despite high ownership concentration at 72.62%. This "skin in the game" demonstrates confidence despite the higher tax cost, while the dedicated oversight committee and postal ballot mechanism ensure governance standards. AnnualReports +1
CyberTech Systems's buyback of 7.55% of consolidated free reserves represents a measured approach that preserves financial flexibility. The company maintains a debt-free balance sheet with strong margins (20.28% EBITDA, 13.64% net), ensuring capacity for future strategic investments while returning capital to shareholders. Others +1
The buyback decisions reflect deep industry-specific assessments of growth opportunities.
Wipro faces IT sector constraints including macroeconomic uncertainty, intense competition from TCS, Infosys, Accenture, and Capgemini, and margin pressure. Recent small acquisitions (Applied Value Technologies for $40 million, Aggne Global for $66 million) represent tactical capability enhancements rather than strategic transformation. The company is prioritizing internal AI platform investment and organic growth through large deal wins ($5.4 billion in FY25, up 17.5% YoY) over expensive acquisitions in a richly valued sector. Transcripts
Bajaj Auto operates in a two-wheeler industry facing EV transition challenges. While Chetak EV capacity at 50,000 units per month is expected to maximize, requiring quantum expansion planned for 2027-28, current capacity is sufficient for near-term demand. The company is taking a measured approach to avoid EV market bubble risks, with industry concerns about overcapacity and utilization challenges. This justifies returning capital now while maintaining optionality for future expansion. Transcripts +1
Zydus Lifesciences balances substantial R&D investment (8% of revenue expectations) with shareholder returns. The company has a robust pipeline including Saroglitazar for PBC, Desidustat in China, and a 505(b)(2) portfolio. Biologics scale-up is expected by FY29-30, requiring continued investment. The balanced approach acknowledges these opportunities while returning capital to shareholders. Transcripts +2
Dhanuka Agritech faces agrochemical industry dynamics including climate variability, regulatory pressure, and international expansion challenges. The company is pursuing measured growth through Dahej technical facility optimization, new product launches (8+ molecules under 9(3)/9(4) registrations), and cautious international expansion. The buyback reflects a risk-adjusted approach given industry cyclicality and expansion challenges. Transcripts
The Finance Act 2026 has fundamentally altered corporate capital allocation, creating a permanent structural advantage for buybacks as a shareholder return mechanism. The clustering of buyback announcements within 49 days of implementation demonstrates rapid strategic adaptation, with each company's approach reflecting its specific cash generation profile, growth opportunities, and industry dynamics.
